Lv1
8 积分 2024-09-09 加入
LAG3 (CD223) as a cancer immunotherapy target
3小时前
待确认
Novel human single-domain antibodies exert potent anti-tumor activity by targeting EGF-like repeat epitope of EpCAM
4个月前
已完结
Novel human single-domain antibodies exert potent anti-tumor activity by targeting EGF-like repeat epitope of EpCAM
4个月前
已关闭